Exposure to space radiation reduces ability of intestinal cells to destroy oncoprotein
Two studies funded by NASA and presented at the AACR Annual Meeting 2013 help explain why space radiation may increase the risk of colorectal cancer in humans.
Cancer
Apr 09, 2013 |
not rated yet |
0
New technology spots drugs' early impact on cancer
A new preclinical technology enables researchers to quickly determine if a particular treatment is effective against gastrointestinal stromal tumors (GISTs), providing a boost to animal research and possibly patient care, ...
Cancer
Apr 09, 2013 |
not rated yet |
0
Is medical therapy a better and safer choice than angioplasty
The decision to perform an invasive procedure to open clogged arteries in the heart instead of first trying medication and lifestyle changes may not reduce a patient's risk of death or of a major cardiac ...
Cardiology
Apr 09, 2013 |
not rated yet |
0
25 percent don't complete recommended breast cancer treatment
One-quarter of women who should take hormone-blocking therapies as part of their breast cancer treatment either do not start or do not complete the five-year course, according to a new study led by University of Michigan ...
Cancer
Apr 09, 2013 |
not rated yet |
0
Chronic pain ranks well below drug addiction as a major health problem in new poll
A new national public opinion poll commissioned by Research!America shows only 18% of respondents believe chronic pain is a major health problem, even though a majority of Americans (63%) say they know someone who experienced ...
Medications
Apr 09, 2013 |
1 / 5 (1) |
0
Rigosertib Phase 1 results lead to disease-focused Phase 2 development
Results of a phase 1 clinical trial reported at the American Association for Cancer Research (AACR) annual conference show that orally administered Rigosertib is well tolerated in patients with advanced solid tumors. This ...
Cancer
Apr 09, 2013 |
not rated yet |
0
Researchers identify gene variations that predict chemotherapy side effects
Seemingly benign differences in genetic code from one person to the next could influence who develops side effects to chemotherapy, a Mayo Clinic study has found. The study identified gene variations that can predispose people ...
Cancer
Apr 09, 2013 |
5 / 5 (1) |
0
|
New target plus new drug equals death of melanoma cells
Collaborative research presented by the University of Colorado Cancer Center, the University of North Carolina at Chapel Hill, Harvard Medical School and the University of Pittsburgh, at the American Association for Cancer ...
Cancer
Apr 09, 2013 |
5 / 5 (1) |
0
Majority of Americans now favor legalizing marijuana
(HealthDay)—A majority of Americans (52 percent) now favor legalizing marijuana, and 72 percent feel that the government efforts to enforce marijuana laws are not worth their cost, according to research ...
Health
Apr 09, 2013 |
5 / 5 (1) |
0
A hijacking of healthy cellular circuits
Proteins that control cell growth are often mutated in cancer, and their aberrant signaling drives the wild proliferation of cells that gives rise to tumors. One such protein, the epidermal growth factor receptor (EGFR), ...
Cancer
Apr 08, 2013 |
not rated yet |
0
Sustained stress heightens risk of miscarriage
Several studies have examined the impact of stress on a pregnancy – both chronic stress, such as workload, and acute stress associated with traumatic events like the 9/11 terrorist attacks. They conclude ...
Health
Apr 08, 2013 |
not rated yet |
0
Research advances therapy to protect against dengue virus
Nearly half of the world's population is at risk of infection by the dengue virus, yet there is no specific treatment for the disease. Now a therapy to protect people from the virus could finally be a step ...
Diseases, Conditions, Syndromes
Apr 08, 2013 |
not rated yet |
0
|
Penis size does matter to women, researchers say in PNAS study (w/ Video)
The eternal question of whether penis size matters to women has been probed by a team of international scientists who reported on Monday that yes, ladies do find larger men more attractive.
Psychology & Psychiatry
Apr 08, 2013 |
3.6 / 5 (22) |
23
Nearly half of breast cancer patients at risk of having BRCA mutations not sent for genetic testing
Only 53 percent of newly diagnosed breast cancer patients who were at high risk of carrying a BRCA 1 or BRCA 2 mutation – based on age, diagnosis, and family history of breast or ovarian cancer – reported that their doctors ...
Cancer
Apr 08, 2013 |
not rated yet |
0
AKT inhibitor AZD5363 well tolerated, yielded partial response in patients with advanced solid tumors
The investigational drug AZD5363, which has shown activity in preclinical studies, was well tolerated in humans, and two patients with advanced solid tumors showed partial response, according to data presented at the AACR ...
Cancer
Apr 08, 2013 |
5 / 5 (1) |
0
